160 related articles for article (PubMed ID: 9273107)
1. [Comparative randomized controlled study between human follicle- stimulating hormone (FSH-HP) and human menopausal gonadotropins (hMG) in in vitro fertilization].
Mayenga JM; Belaisch-Allart J; Chouraqui A; Tesquier L; Serkine AM; Cohen J; Plachot M; Mandelbaum J
Contracept Fertil Sex; 1997 May; 25(5):371-4. PubMed ID: 9273107
[TBL] [Abstract][Full Text] [Related]
2. [A randomized, controlled trial comparing follicle stimulating hormone (FSH) to human menopausal gonadotropin (hMG) in fertilization in vitro].
Daya S; Gumby J; Hughes EG; Collins JA; Sagle MA
Contracept Fertil Sex; 1995 Dec; 23(12):766-71. PubMed ID: 8556078
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial.
Andersen AN; Devroey P; Arce JC
Hum Reprod; 2006 Dec; 21(12):3217-27. PubMed ID: 16873892
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of highly purified human menopausal gonadotropin vs. recombinant follicle-stimulating hormone in first-cycle in vitro fertilization-intracytoplasmic sperm injection patients.
Hompes PG; Broekmans FJ; Hoozemans DA; Schats R;
Fertil Steril; 2008 Jun; 89(6):1685-93. PubMed ID: 17681325
[TBL] [Abstract][Full Text] [Related]
5. [Influence of infertility etiology and follicular stimulation protocols on pregnancy outcomes by in vitro fertilization].
Merviel P; Antoine JM; Alvarez S; Cornet D; Plachot M; Mandelbaum J; Uzan S; Salat-Baroux J
Contracept Fertil Sex; 1996 Feb; 24(2):157-62. PubMed ID: 8611938
[TBL] [Abstract][Full Text] [Related]
6. A retrospective review comparing the use of Gonal-F and Metrodin-HP for in-vitro fertilisation (IVF).
Lee C; Mak FS; Keith J; Welsh D; Yapp P; Chin R
Med J Malaysia; 2003 Mar; 58(1):94-8. PubMed ID: 14556331
[TBL] [Abstract][Full Text] [Related]
7. Human menopausal gonadotropin versus highly purified-hMG in controlled ovarian hyperstimulation for in-vitro fertilisation: does purity improve outcome?
Orvieto R; Meltcer S; Liberty G; Rabinson J; Anteby EY; Nahum R
Gynecol Endocrinol; 2010 Oct; 26(10):733-5. PubMed ID: 20500109
[TBL] [Abstract][Full Text] [Related]
8. Clinical comparison of ovarian stimulation and luteal support agents in patients undergoing GnRH antagonist IVF cycles.
Miller CE; Zbella E; Webster BW; Doody KJ; Bush MR; Collins MG
J Reprod Med; 2013; 58(3-4):153-60. PubMed ID: 23539885
[TBL] [Abstract][Full Text] [Related]
9. [Use of purified FSH in female infertility].
Antoine JM; Salat-Baroux J
Contracept Fertil Sex; 1993 Apr; 21(4):301-6. PubMed ID: 7951630
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of recombinant human follicle-stimulating hormone in improving oocyte quality in assisted reproductive techniques.
Cheon KW; Byun HK; Yang KM; Song IO; Choi KH; Yoo KJ
J Reprod Med; 2004 Sep; 49(9):733-8. PubMed ID: 15493565
[TBL] [Abstract][Full Text] [Related]
11. Pure and highly purified follicle-stimulating hormone alone or in combination with human menopausal gonadotrophin for ovarian stimulation after pituitary suppression in in-vitro fertilization.
Balasch J; Fábregues F; Creus M; Moreno V; Puerto B; Peñarrubia J; Carmona F; Vanrell JA
Hum Reprod; 1996 Nov; 11(11):2400-4. PubMed ID: 8981119
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy of highly purified hMG versus recombinant FSH in IVF/ICSI cycles: a meta-analysis.
Jee BC; Suh CS; Kim YB; Kim SH; Moon SY
Gynecol Obstet Invest; 2010; 70(2):132-7. PubMed ID: 20389096
[TBL] [Abstract][Full Text] [Related]
13. Randomized controlled trial of follicle stimulating hormone versus human menopausal gonadotrophin in in-vitro fertilization.
Daya S; Gunby J; Hughes EG; Collins JA; Sagle MA
Hum Reprod; 1995 Jun; 10(6):1392-6. PubMed ID: 7593503
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of mixed protocols with Bravelle (human-derived FSH) and Repronex (hMG) to assess clinical efficacy (EMBRACE) in women undergoing in vitro fertilization.
Keye WR; Marrs RP; Check JH; Schnell V; Surrey M; Marshall DC;
Fertil Steril; 2004 Aug; 82(2):348-57. PubMed ID: 15302283
[TBL] [Abstract][Full Text] [Related]
15. Output and input from the controversy: recombinant FSH versus hMG.
Check JH
Fertil Steril; 2004 May; 81(5):1428-9; author reply 1429. PubMed ID: 15136126
[No Abstract] [Full Text] [Related]
16. An economic evaluation of highly purified HMG and recombinant FSH based on a large randomized trial.
Wechowski J; Connolly M; McEwan P; Kennedy R
Reprod Biomed Online; 2007 Nov; 15(5):500-6. PubMed ID: 18028739
[TBL] [Abstract][Full Text] [Related]
17. Highly purified hMG achieves better pregnancy rates in IVF cycles but not ICSI cycles compared with recombinant FSH: a meta-analysis.
Al-Inany HG; Abou-Setta AM; Aboulghar MA; Mansour RT; Serour GI
Gynecol Endocrinol; 2009 Jun; 25(6):372-8. PubMed ID: 19340668
[TBL] [Abstract][Full Text] [Related]
18. [IVF in sterility related to ovarian dystrophy].
Chrétien MF; Guerrier C; Denis A; Malkani K
Contracept Fertil Sex; 1993 Dec; 21(12):907-10. PubMed ID: 8130824
[TBL] [Abstract][Full Text] [Related]
19. A prospective randomized noninferiority study comparing recombinant FSH and highly purified menotropin in intrauterine insemination cycles in couples with unexplained infertility and/or mild-moderate male factor.
Sagnella F; Moro F; Lanzone A; Tropea A; Martinez D; Capalbo A; Gangale MF; Spadoni V; Morciano A; Apa R
Fertil Steril; 2011 Feb; 95(2):689-94. PubMed ID: 20869704
[TBL] [Abstract][Full Text] [Related]
20. Results of controlled ovarian stimulation for ART in poor responders according to the short protocol using different gonadotrophins combinations.
Loutradis D; Elsheikh A; Kallianidis K; Drakakis P; Stefanidis K; Milingos S; Michalas S
Arch Gynecol Obstet; 2004 Dec; 270(4):223-6. PubMed ID: 13680266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
